Yanyan Ma

Shenzhen, 518055, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Histidine metabolic reprogramming drives oxidative stress induced mtDNA release to promote necroptosis and airway inflammation in severe asthma.

Histidine metabolic reprogramming drives oxidative stress induced mtDNA release to promote necroptosis and airway inflammation in severe asthma.

Journal: Redox biology

Published: June 23, 2026

Nrp1 Signaling Reprograms Glutathione Metabolism to Drive Mitochondrial Dysfunction in Severe Asthma.

Nrp1 Signaling Reprograms Glutathione Metabolism to Drive Mitochondrial Dysfunction in Severe Asthma.

Journal: Antioxidants (Basel, Switzerland)

Published: February 22, 2026

A Lightweight Intrusion Detection System with Dynamic Feature Fusion Federated Learning for Vehicular Network Security.

A Lightweight Intrusion Detection System with Dynamic Feature Fusion Federated Learning for Vehicular Network Security.

Journal: Sensors (Basel, Switzerland)

Published: June 18, 2025

YTHDF1-mediated mitochondrial dysfunction and allergic airway inflammation by interaction with β-catenin/TCF4 signaling.

YTHDF1-mediated mitochondrial dysfunction and allergic airway inflammation by interaction with β-catenin/TCF4 signaling.

Journal: International immunopharmacology

Published: January 03, 2025

Bongkrekic acid alleviates airway inflammation via breaking the mPTP/mtDAMPs/RAGE feedback loop in a steroid-insensitive asthma model.

Bongkrekic acid alleviates airway inflammation via breaking the mPTP/mtDAMPs/RAGE feedback loop in a steroid-insensitive asthma model.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 11, 2024

Inhibition of xanthine oxidase by allopurinol suppresses HMGB1 secretion and ameliorates experimental asthma.

Inhibition of xanthine oxidase by allopurinol suppresses HMGB1 secretion and ameliorates experimental asthma.

Journal: Redox biology

Published: December 06, 2023

The value of bronchodilator response in FEV1 and FeNO for differentiating between chronic respiratory diseases: an observational study.

The value of bronchodilator response in FEV1 and FeNO for differentiating between chronic respiratory diseases: an observational study.

Journal: European journal of medical research

Published: November 05, 2023

A Low Eosinophil to Platelet Ratio as a Worse Prognostic Index for Emergency Department Attendance in Acute Exacerbation of COPD.

A Low Eosinophil to Platelet Ratio as a Worse Prognostic Index for Emergency Department Attendance in Acute Exacerbation of COPD.

Journal: International journal of chronic obstructive pulmonary disease

Published: October 24, 2023

Corrigendum to: "Mitoquinone ameliorated airway inflammation by stabilizing β-catenin destruction complex in a steroid-insensitive asthma model" [Biomed. Pharmacother. vol. 162 (2023) 114680].

Corrigendum to: "Mitoquinone ameliorated airway inflammation by stabilizing β-catenin destruction complex in a steroid-insensitive asthma model" [Biomed. Pharmacother. vol. 162 (2023) 114680].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 24, 2023

Mitoquinone ameliorated airway inflammation by stabilizing β-catenin destruction complex in a steroid-insensitive asthma model.

Mitoquinone ameliorated airway inflammation by stabilizing β-catenin destruction complex in a steroid-insensitive asthma model.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 11, 2023

Showing 1-10 of 10

Last Updated: 09/26/2026